Description
Nufox is not currently approved or widely used in the treatment of colorectal cancer. Its clinical efficacy and safety profile have yet to be established through clinical trials specific to colorectal cancer patients.
Mechanism of Action
Nufox is an investigational drug and its mechanism of action has not been fully elucidated or approved by the FDA for use in colorectal cancer.
Side Effects
No side effects have been reported for Nufox as it is not approved or in use for colorectal cancer treatment; further studies are needed to determine potential adverse reactions.
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT03428958
Phase 1
Archived
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
United States, France, United Kingdom
Quick Info
| Category | Other Medications |
 EMA Status | Not submitted to EMA |
 Spain Access | Not available |
| Clinical Trials | 1 |
Related Medications
Uracil
Other Medications
781 trials
Leucovorin
Other Medications
641 trials
Paclitaxel
Other Medications
54 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Trifluridine
Other Medications
48 trials
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.